what's the best time of day to take tirzepatide What is Zepbound? 5 Tips for Taking Zepbound

TRIUMPH-4 enrolled participants with obesity plus knee osteoarthritis

Parallel research into oral, transdermal, and inhalable nanocarriers promises to transform insulin delivery into a minimally invasive, patient-friendly modality (108)

Russell-Jones D, Babazono T, Cailleteau R et al (2023) Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial

11,2325 EMPA-REG OUTCOME was a randomized, double-blind, placebo-controlled trial involving 7,020 patients with T2D and established cardiovascular disease (CVD)